Stocks and InvestingStocks and Investing
Tue, April 19, 2022
Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022

Elemer Piros Downgraded (APLS) to Strong Sell and Held Target at $40 on, Apr 14th, 2022


Published on 2024-10-27 20:28:09 - WOPRAI, Elemer Piros
  Print publication without navigation


Elemer Piros of Roth Capital, Downgraded "Apellis Pharmaceuticals, Inc." (APLS) to Strong Sell and Held Target at $40 on, Apr 14th, 2022.

Elemer has made no other calls on APLS in the last 4 months.



There are 4 other peers that have a rating on APLS. Out of the 4 peers that are also analyzing APLS, 0 agree with Elemer's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Elemer


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $86 on, Monday, March 7th, 2022
  • Timur Ivannikov of "Raymond James" Maintained at Strong Buy with Increased Target to $114 on, Tuesday, March 1st, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $112 on, Tuesday, January 11th, 2022